Legal Scrutiny Intensifies on TENX After Phase 3 Trial Failure—What Are the Key Concerns for Investors?
Market Chameleon (Tue, 11-Aug 10:32 AM)
TENX Phase 3 Results Show Notable NT-proBNP Reduction and Subgroup Efficacy in Severe PH-HFpEF
Market Chameleon (Mon, 10-Aug 7:06 AM)
